Skift Take
Vaccine requirements are a no-brainer to resume U.S. borders to the remainder of the world. But don’t anticipate this to happen overnight– the Delta version is still a significant headwind and issue to those who need to approve any kind of reopening.
Cameron Sperance
White Home coronavirus action planner Jeff Zients stated on Wednesday the United States is developing a “new system for international travel” that will include brand-new strong mitigation procedures like contact tracing.
Zients informed the U.S. Travel and Tourist Board of advisers the administration does not plan to instantly relax any travel constraints since of COVID-19 Delta variant cases.
“We are exploring considering vaccination requirements for foreign nationals taking a trip to the United States,” Zients stated.
Reuters initially reported early in August that the White House was establishing vaccine requirements that could cover nearly all foreign visitors.
The extraordinary U.S. travel constraints were first troubled China in January 2020 to resolve the spread of COVID-19. Various other countries have been added, most recently India, in May.
The administration wanted to raise travel limitations “as soon as we can,” Zients said, adding it was “working now to be all set to change the existing constraints with a new system for worldwide travel that is much safer, more powerful and sustainable.”
The United States currently bars most non-U.S. people who within the last 14 days have remained in the United Kingdom, the 26 Schengen countries in Europe without border controls, Ireland, China, India, South Africa, Iran and Brazil.
It independently bars non-essential travel by most non-U.S. citizens at U.S. land borders with Mexico and Canada.
Numerous critics of the constraints say they no longer make good sense because some nations with high rates of COVID-19 infections are not on the restricted list while some nations on the list have the pandemic under control.
Copyright (2021) Thomson Reuters. Click for limitations
This short article was written by David Shepardson from Reuters and was legally licensed through the Industry Dive publisher network. Please direct all licensing questions to [email protected]